Kleiman S, Bernstein J, Schwartz G, Eisensmith R C, Woo S L, Shiloh Y
Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Hum Mutat. 1992;1(4):340-3. doi: 10.1002/humu.1380010413.
Phenylketonuria (PKU) and benign hyperphenylalaninemia (HPA) result from different combinations of mutations at the locus for phenylalanine hydroxylase (PAH). While some of these mutations show widespread ethnic distribution, others are unique to specific communities. We report here the first point mutation common among Palestinian Arabs. The mutation (IVS2nt1) involves a dinucleotide substitution (Gg-->Aa) at the donor splice site of intron 2 of the PAH gene and abolishes a recognition site of the restriction enzyme MnlI. IVS2nt1 is associated with two PAH polymorphic haplotypes, 7 and 42. Homozygotes for this mutation are affected with severe, classical PKU. Compound heterozygotes carrying the IVS2nt1 allele and one of several other yet unknown mutations show different degrees of benign HPA.
苯丙酮尿症(PKU)和良性高苯丙氨酸血症(HPA)是由苯丙氨酸羟化酶(PAH)基因座上不同的突变组合引起的。虽然其中一些突变具有广泛的种族分布,但其他一些突变则是特定群体所特有的。我们在此报告巴勒斯坦阿拉伯人当中首次发现的一个点突变。该突变(IVS2nt1)涉及PAH基因内含子2供体剪接位点的二核苷酸替换(Gg→Aa),并消除了限制性内切酶MnlI的一个识别位点。IVS2nt1与两种PAH多态性单倍型7和42相关。该突变的纯合子患有严重的经典型PKU。携带IVS2nt1等位基因和其他几种未知突变之一的复合杂合子表现出不同程度的良性HPA。